43 Shortening the scan duration 11. Rodriguez-Vieitez E, Leuzy A, Chiotis K, et al. Comparability of [(18)F]THK5317 and [(11)C] PIB blood flow proxy images with [(18)F]FDG positron emission tomography in Alzheimer’s disease. Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 2017; 37: 740–749. 2016/04/24. https://doi.org/10.1177/0271678x16645593 12. Peretti DE, Vállez García D, Reesink FE, et al. Diagnostic performance of regional cerebral blood flow images derived from dynamic PIB scans in Alzheimer’s disease. EJNMMI research 2019; 9: 59. 2019/07/06. https://doi.org/10.1186/s13550-019-0528-3 13. Chen YJ, Rosario BL, Mowrey W, et al. Relative 11C-PiB delivery as a proxy of relative CBF: quantitative evaluation using single-session 15O-water and 11C-PiB PET. Journal of nuclear medicine: official publication, Society of Nuclear Medicine 2015; 56: 1199–1205. 2015/06/06. https://doi.org/10.2967/jnumed.114.152405 14. Ottoy J, Verhaeghe J, Niemantsverdriet E, et al. (18)F-FDG PET, the early phases and the delivery rate of (18)F-AV45 PET as proxies of cerebral blood flow in Alzheimer’s disease: validation against (15)OH(2)O PET. Alzheimer’s & dementia : the journal of the Alzheimer’s Association 2019; 15: 1172–1182. 2019/08/14. https://doi.org/10.1016/j.jalz.2019.05.010 15. Peretti DE, Vállez García D, Reesink FE, et al. Correction: Relative cerebral flow from dynamic PIB scans as an alternative for FDG scans in Alzheimer’s disease PET studies. PloS one 2019; 14: e0214187. 2019/03/19. https://doi.org/10.1371/journal.pone.0214187 16. van Berckel BN, Ossenkoppele R, Tolboom N, et al. Longitudinal amyloid imaging using 11C-PiB: methodologic considerations. Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2013; 54: 1570–1576. 2013/08/14. https://doi.org/10.2967/ jnumed.112.113654 17. Golla SS, Timmers T, Ossenkoppele R et al (2017) Quantification of tau load using [18 F] AV1451 PET. Mol Imaging Biol 19:963–971 18. Golla SS, Wolters EE, Timmers T, et al. Parametric methods for [18F] flortaucipir PET. Journal of Cerebral Blood Flow & Metabolism 2018: 0271678X18820765 19. Timmers T, Ossenkoppele R, Visser D et al (2019) Test-retest repeatability of [18F]Flortaucipir PET in Alzheimer’s disease and cognitively normal individuals. J Cereb Blood Flow Metab in press in press 20. Wolters EE, Golla SS, Timmers T et al (2018) A novel partial volume correction method for accurate quantification of [18 F] flortaucipir in the hippocampus. EJNMMI Res 8:79 21. Timmers T, Ossenkoppele R, Wolters EE, Verfaillie SCJ, Visser D, Golla SSV, Barkhof F, Scheltens P, Boellaard R, van der Flier WM, van Berckel BNM (2019) Associations between quantitative [18 F] flortaucipir tau PET and atrophy across the Alzheimer’s disease spectrum. Alzheimers Res Ther 11:60 22. Barret O, Alagille D, Sanabria S, et al. Kinetic modeling of the tau PET tracer (18)F-AV-1451 in human healthy volunteers and Alzheimer disease subjects. Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2017; 58: 1124–1131. 2016/12/03. https:// doi.org/10.2967/jnumed.116.182881 23. Boellaard R, van Lingen A, van Balen SC, et al. Characteristics of a new fully programmable blood sampling device for monitoring blood radioactivity during PET. European journal of nuclear medicine 2001; 28: 81–89. 2001/02/24. https://doi.org/10.1007/s002590000405 2
RkJQdWJsaXNoZXIy MjY0ODMw